Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

NEWS AND EVENTS

February 10, 2010

Milestones met in 2009 lead to optimistic outlook for Theratechnologies

Theratechnologies announces financial results for the fourth quarter and reviews highlights for the year 2009

  • Conclusion of an agreement with EMD Serono
  • Filing of a New Drug Application with the FDA
  • Receipt of a US $10 M milestone payment
  • Invitation to appear before a FDA Advisory Committee
  • Granting of a patent for tesamorelin in Brazil
  • $65 M liquidity position

Additional documentation (PDF : 72.71 K)

Additional documentation (PDF : 73.16 K)